John A. Ornell - Nov 6, 2025 Form 4 Insider Report for BRUKER CORP (BRKR)

Role: Director
Signature: /s/ Michael Simone, Attorney-in-Fact
Stock symbol: BRKR
Transactions as of: Nov 6, 2025
Transactions value $: -$3,087
Form type: 4
Date filed: 11/10/2025, 04:43 PM
Previous filing: May 14, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
ORNELL JOHN A	Director	BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA	/s/ Michael Simone, Attorney-in-Fact	2025-11-10	0001186875

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BRKR	Common Stock	Options Exercise	$240K	+10K	+31.8%	$24.00	41.4K	Nov 6, 2025	Direct
transaction	BRKR	Common Stock	Sale	-$243K	-6.23K	-15.04%	$39.00	35.2K	Nov 6, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BRKR	Stock Option (right to buy)	Options Exercise	$0	+10K		$0.00	10K	Nov 6, 2025	Common Stock	10K	$24.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.0001 to $39.0101, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The stock option granted to the Reporting Person on January 5, 2016 (the "Original Grant Date") vested in equal installments on the first, second and third anniversaries of the Original Grant Date.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.0001 to $39.0101, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The stock option granted to the Reporting Person on January 5, 2016 (the "Original Grant Date") vested in equal installments on the first, second and third anniversaries of the Original Grant Date.